|
Real-time
Euronext Paris
05:28:16 2026-11-05 EST
|
5-day change | 1st Jan Change | ||
| 9.260 EUR | +0.65% |
|
+4.04% | -45.04% |
| 10-19 | Sensorion Announces Appointment of Peter Weber as Chief Medical Officer, Effective November 2, 2026 | CI |
| 10-19 | Sensorion rallies after appointment of chief medical officer |
Company Valuation: Sensorion
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 153.4 | 29.56 | 80.38 | 191 | 101.3 | 94.81 | - |
| Change | - | -80.74% | 171.97% | 137.65% | -47% | -6.37% | - |
| Enterprise Value (EV) 1 | 107.4 | 7.116 | 80.38 | 126.4 | 55.03 | 20.81 | 19.81 |
| Change | - | -93.38% | 1,029.56% | 57.22% | -56.45% | -62.19% | -4.81% |
| P/E | -10.1x | -1.28x | -2.53x | -7.07x | -3.37x | -2.75x | -4.11x |
| PBR | - | - | - | - | - | - | - |
| PEG | - | -0x | 0.1x | 0.2x | -0.3x | 0.1x | 0.1x |
| Capitalization / Revenue | 35.3x | 5.9x | 14.1x | 28.7x | 17.4x | 20.3x | 5.95x |
| EV / Revenue | 24.7x | 1.42x | 14.1x | 19x | 9.47x | 4.46x | 1.24x |
| EV / EBITDA | -7.31x | -0.32x | -3.65x | -4.64x | -1.88x | -0.6x | -0.92x |
| EV / EBIT | -7.15x | -0.31x | -3.6x | -4.45x | -1.79x | -0.59x | -0.9x |
| EV / FCF | -9.56x | -0.31x | - | -5.74x | -2x | -0.77x | 13.5x |
| FCF Yield | -10.5% | -321% | - | -17.4% | -50% | -130% | 7.42% |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -9.5 | -14.5 | -8.5 | -4.5 | -5 | -3.35 | -2.24 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 4.349 | 5.006 | 5.698 | 6.653 | 5.814 | 4.663 | 15.92 |
| EBITDA 1 | -14.69 | -22.37 | -22.04 | -27.24 | -29.31 | -34.95 | -21.55 |
| EBIT 1 | -15.02 | -23.14 | -22.31 | -28.4 | -30.75 | -35.4 | -21.93 |
| Net income 1 | -15.14 | -23.21 | -22.06 | -25.97 | -29.43 | -36 | -28.79 |
| Net Debt 1 | -46.02 | -22.44 | - | -64.66 | -46.22 | -74 | -75 |
| Reference price 2 | 96.300 | 18.500 | 21.500 | 31.800 | 16.850 | 9.200 | 9.200 |
| Nbr of stocks (in thousands) | 1,593 | 1,598 | 3,739 | 6,007 | 6,009 | 10,305 | - |
| Announcement Date | 4/28/22 | 3/16/23 | 2/29/24 | 3/14/25 | 3/17/26 | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.75x | 4.46x | -0.6x | - | 106M | ||
| 17.65x | 6.7x | 12.84x | 1.69% | 66.87B | ||
| 38.55x | 6.82x | 20.37x | 0.84% | 56.55B | ||
| 30.7x | 8.25x | 27.69x | 0.05% | 57.2B | ||
| 34.43x | 3.28x | 14.15x | -.--% | 43.47B | ||
| -20.73x | 201.32x | -22.15x | -.--% | 42.8B | ||
| 49.83x | 5.75x | 31.5x | -.--% | 42.95B | ||
| 43.47x | 7.75x | 25.96x | -.--% | 32.11B | ||
| 34.02x | 8.4x | 21.89x | 0.39% | 34.01B | ||
| -68.94x | 12.7x | -71.03x | -.--% | 24.13B | ||
| Average | 15.62x | 26.54x | 6.06x | 0.33% | 40.02B | |
| Weighted average by Cap. | 21.88x | 27.87x | 11.19x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALSEN Stock
- Valuation Sensorion
Select your edition
All financial news and data tailored to specific country editions
















